![](/img/cover-not-exists.png)
Use of pharmacogenetics in bioequivalence studies to reduce sample size: an example with mirtazapine and CYP2D6
González-Vacarezza, N, Abad-Santos, F, Carcas-Sansuan, A, Dorado, P, Peñas-LLedó, E, Estévez-Carrizo, F, LLerena, ALanguage:
english
Pages:
12
Journal:
The Pharmacogenomics Journal
DOI:
10.1038/tpj.2012.29
Date:
June, 2012
File:
PDF, 216 KB
english, 2012